A recent study suggests that calcium can mimic estrogen to interact with ligand binding domain of estrogen receptors in breast cancer cells and combine a calcium channel blocker with an antiestrogen reversed resistance to the antiestrogen in breast cancer (Divekar et al., 2011; Cyrus et al., 2021). The gene discussed is ESR1; the disease is breast carcinoma.